This study advocates for a shift from adversarial tobacco regulation to a constructive approach. It suggests the Food and Drug Administration (FDA) should promote cigarette safety innovations and provide comparative risk information to consumers.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: